As a result, the current investigation indicated that the described thiazolyl pyridines are promising EGFR inhibitors and pave the way for the synthesis of other libraries based on the reported scaffold, which may eventually result in the creation of an effective therapy for lung cancer. This evidence concerns the gene EGFR and lung cancer.